Stockreport
MiMedx Group Inc (MDXG) Q1 2026 Earnings Call Highlights: Navigating Growth and Challenges [Yahoo! Finance]
Last mimedx group, inc earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
Positive Points MiMedx Group Inc ( NASDAQ:MDXG ) reported a 13% growth in its surgical business for Q1 2026, showcasing strong performance in this segment. The company ended the quarter with a robust cash position of $142 million, providing financial stability. MiMedx Group Inc ( NASDAQ:MDXG ) completed enrollment in its EpiEffect randomized control trial, indicating progress in its research initiatives. The company launched new surgical products, including AmnioFix Thyroid Shields, contributing to its diversified product portfolio. MiMedx Group Inc ( NASDAQ:MDXG ) has initiated a $100 million share repurchase program, reflecting confidence in its financial health and commitment to shareholder value. Negative Points The wound care business experienced a significant 60% decline in sales year-over-year, heavily impacted by changes in Medicare reimbursement policies. The company reported an adjusted EBITDA loss of $12 million for Q1 2026, indicating financial challenges.
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | MDXG | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
MDXG alerts
MDXG alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXG alerts
High impacting MiMedx Group, Inc news events
Weekly update
A roundup of the hottest topics
MDXG
NEWS
NEWS
- MiMedx Group (MDXG) had its price target lowered by Citizens Jmp from $7.00 to $6.00. They now have a "market outperform" rating on the stock.[MarketBeat]
- MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript [Seeking Alpha][Seeking Alpha]
- Mimedx expects $260M-$290M 2026 net sales amid $40M cost cuts and wound care reimbursement disruption [Seeking Alpha][Seeking Alpha]
- MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance][Yahoo! Finance]
- MiMedx Group Q1 Earnings Call Highlights [Yahoo! Finance][Yahoo! Finance]
- More
MDXG
SEC Filings
SEC Filings
- 4/29/26 - Form DEFA14A
- 4/29/26 - Form ARS
- 4/29/26 - Form DEF
- MDXG's page on the SEC website
- More